Markets
← Back to Stocks
CVS
CVS HEALTH CORP
Health Care · Health Care Services
$71.86
-1.59%
Vol: 0.3M
Araverus Market Read
Thursday, March 19, 2026
CVS completes Rite Aid acquisition, settles Medicare fraud suit while reaffirming 2026 EPS guidance.
CVS Health completed the Rite Aid acquisition adding 9 million patients and settled a $117.7 million Medicare Advantage fraud case. The company reaffirmed 2026 EPS guidance of $7.00-$7.20 and declared a $0.665 dividend payable May 4. Pre-market stock decreased 0.49% to $76.21 with 24 analysts recommending buys and Strong Buy consensus averaging 2026 guidance.
Price 50d 200d
Previous Market Reads
2 of 2 daysSector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$91.4B
P/E (TTM)51.7
Forward P/E8.8
Beta0.46
Div Yield364.00%
Prev Close$73.02
RSI (14-Day)
20Oversold
0305070100
52-Week Range
$58.35$71.86$85.15
From High-15.6%
From Low+23.2%
Moving Averages
50d SMA
$77.61-7.4%
200d SMA
$73.21-1.8%
Price below 200d MA — bearish structure.
Returns
1W
-5.5%
1M
-7.6%
3M
-7.5%
6M
-1.3%
1Y
+10.4%
YTD
-9.6%
Volume
Today329K
20d Avg7.8M
Ratio0.04x